MultiPlan (NYSE:MPLN – Get Free Report) will release its earnings data before the market opens on Tuesday, November 5th. Analysts expect MultiPlan to post earnings of ($2.40) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
MultiPlan (NYSE:MPLN – Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported ($1.20) EPS for the quarter, topping analysts’ consensus estimates of ($1.60) by $0.40. The firm had revenue of $233.48 million for the quarter, compared to the consensus estimate of $253.59 million. MultiPlan had a negative return on equity of 8.90% and a negative net margin of 122.73%. During the same quarter last year, the business posted ($2.40) earnings per share. On average, analysts expect MultiPlan to post $-7 EPS for the current fiscal year and $-7 EPS for the next fiscal year.
MultiPlan Price Performance
MPLN stock opened at $9.16 on Monday. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 7.48. The firm has a market cap of $147.84 million, a price-to-earnings ratio of -0.13 and a beta of 0.46. MultiPlan has a 52-week low of $6.35 and a 52-week high of $69.20.
Insider Activity
Analysts Set New Price Targets
MPLN has been the subject of several recent analyst reports. Piper Sandler reissued a “neutral” rating and set a $40.00 target price (down previously from $80.00) on shares of MultiPlan in a research note on Wednesday, August 7th. Citigroup cut their target price on MultiPlan from $17.20 to $10.00 and set a “neutral” rating for the company in a research note on Monday, September 23rd.
View Our Latest Stock Report on MPLN
MultiPlan Company Profile
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Recommended Stories
- Five stocks we like better than MultiPlan
- Investing in Travel Stocks Benefits
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- How to Find Undervalued Stocks
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Why Invest in High-Yield Dividend Stocks?
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with MarketBeat.com's FREE daily email newsletter.